Swine influenza A: Phase II start

NIH's NIAID will soon begin a double-blind, U.S. Phase II trial to evaluate 1 or 2 doses of 15 or 30 ug of CSL's intramuscular swine influenza A (H1N1) vaccine in 400 healthy adult and elderly volunte...